It is a chemicals private limited company based in Thiruvananthapuram, Kerala, India, established in 2007.
2007 | Thiruvananthapuram, Kerala, India | ActiveMedigard Pharmaceuticals Private Limited, a active private limited company, was established on 16 March 2007 in Thiruvananthapuram, Kerala, India. Engaging in chemical products within the manufacturing sector, it holds CIN: U24233KL2007PTC020505. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Its leadership includes Kalaiselvi Perumal Velautha (Director Appointed In Casual Vacancy), Ajithkumar Lalitha Madhavan (Managing Director). Past directors included Kuruvila Samuel, Lalitha Kesavan. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at B P 1/1522 ,Thempamuttom, Russelpuram P.O, Thiruvananthapuram, Kerala, 695501.
U24233KL2007PTC020505
020505
16 March 2007
₹0.50 M
₹0.50 M
Roc Ernakulam
Unlisted
Active
Explore comprehensive insights into Medigard Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kalaiselvi Perumal Velautha | Director Appointed In Casual Vacancy | 21 Oct 2015 | Current |
| Ajithkumar Lalitha Madhavan | Managing Director | 16 Mar 2007 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 21 Oct 2015 | Past |
| Pramod Abcsdd | Director | 13 Feb 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Medigard Pharmaceuticals Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 207.14% increase. The company also saw a substantial fall in profitability, with a 19891.84% decrease in profit. The company's net worth observed a substantial decline by a decrease of 119.81%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Medigard Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Medigard Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Medigard Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medigard Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Medigard Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was completed.
The activity Medigard Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Ernakulam. was completed.
Kalaiselvi Perumal Velautha was appointed as a Director appointed in casual vacancy was appointed as a Director appointed in casual vacancy on 21 Oct 2015 & has been associated with this company since 10 years 1 month . was recorded as a recent event.
The activity Ajithkumar Lalitha Madhavan was appointed as a Managing Director was appointed as a Managing Director on 16 Mar 2007 & has been associated with this company since 18 years 8 months . was completed.
Progress on Medigard Pharmaceuticals Private Limited was registered on 16 Mar 2007 with Roc Ernakulam & aged 18 years 8 months as per MCA records. was documented.
The CIN of Medigard Pharmaceuticals Private Limited is U24233KL2007PTC020505.
Medigard Pharmaceuticals Private Limited is headquartered at B P 1/1522 ,Thempamuttom, Russelpuram P.O, Thiruvananthapuram, Kerala, 695501.
Medigard Pharmaceuticals Private Limited was incorporated on 16 March 2007.
The current directors of Medigard Pharmaceuticals Private Limited are
The primary industry of Medigard Pharmaceuticals Private Limited is Manufacturing.
Medigard Pharmaceuticals Private Limited is unlisted.
The authorized capital of Medigard Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.
The compliance status of Medigard Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX